Clinical Trials Browser

Prostatic Neoplasms × Hormones × Genitourinary × Clear all

NCT04134260 2026-01-14

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Phase 3 Recruiting

Prostatic Neoplasms

NCT06660862 2026-01-08

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Phase 4 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT03432780 2021-01-22

QRT-SOGUG

Phase 2 Unknown

Prostatic Neoplasms